CE3 Annual Revenue, Number of Employees, Growth and Funding

Overview

Location:
Guilford, CT USA
Total Funding:N/A
Industry:Pharma
Founded:2005
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • CE3's estimated annual revenue is currently $12.3M per year.
  • CE3's estimated revenue per employee is $188,631

Employee Data

  • CE3 has 65 Employees.
  • CE3 grew their employee count by 8% last year.
  • CE3 currently has 1 job openings.

Executive Contacts

NameTitle
Susan DangleDirector, Proposals and Account Operations
Deborah ChurchChief Medical Officer
Darshan KansagaraDirector, Clinical Programming
Sarah SilversDirector, GCP Process Control and Compliance
Stephen BiotySenior Director, Information Management and Implementation
Holly CoulterPresident and CEO
Lori BrozenaAssociate Director Clinical Operations
Joanne DeMusis-KadzielaAssociate Director, CLinical Operations
Melanie DyerDirector, Biometrics
Patricia EdwardsDirector of Clinical Operations

Ce3 is a full-service CRO committed to working with biotechnology companies on emerging therapies and technologies to improve patient lives. Our experience in working exclusively with Biotechs has refined and leveraged our tools and skills to easily accommodate the special requests and customization required by this dynamic environment. Our focus is on early phase development. We know the level of agility, detail, and precision such studies require. Ce3 supports clients in the most cost-effective manner with quality data to facilitate timely decision making. We can execute faster, easier, and better to meet biotech and investor needs. Ce3's depth of experience includes Immuno-Oncology (inclusive of CAR-T), Gene Therapy (multiple therapeutic indications), and other innovative therapies. Our expertise is in Oncology clinical research and clinical trial execution: First in Human Dose Escalation Cohort Management Complex and adaptive study designs Our name, Ce3, represents our core values and serves as the foundation of our operations: a collaborative approach in managing your studies while delivering experience, efficiency and excellence!

keywords:N/A

65

Number of Employees

$12.3M

Revenue (est)

1

Current Jobs

8%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Connecticut Pha...
$6.4M346%N/A
The Scienomics ...
$20.5M10911%N/A
Avara Pharmaceu...
$134.9M71827%N/A
CE3
$12.3M658%N/A
LOXO Oncology
$29.3M15673%N/A

CE3 News

08/12/2019 - ANALYST VIEW - German problems seen cracking CE3 ...

The CE3 economies' resilience to the slowdown in the Euro area, and in Germany specifically, has been remarkable considering the ...

08/26/2019 - Solid – state Lasers Market Size, Status and Forecast 2019 ...

The Study Explore the Product Types of Solid – state Lasers Market: , Tunable near – infrared solid – state lasers, Tunable Ultraviolet Ce3 + ...

08/20/2019 - Solid -State, Fiber,Gas and Dye Lasers Market Aims to ...

... Fiber,Gas and Dye Lasers Market Revenue & Growth Rate by Type [, Tunable near – infrared solid – state lasers, Tunable Ultraviolet Ce3 + ...